Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Rosales Minori — Eleven Biotherapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Rosales Minori

Rosales Minori

Chief Development Officer at Eleven Biotherapeutics, Inc. · on record since Jan 26, 2022

Insider trading activity of Rosales Minori

Transactions on record: 1; since Jan 26, 2022

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 26, 2022

Figures computed from official regulatory filings — methodology.

Companies where Rosales Minori has traded

Eleven Biotherapeutics, Inc.1 tx · Jan 26, 2022

Track record of Rosales Minori

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Rosales Minori

Co-insiders of Rosales Minori

AFEYAN NOUBAREleven Biotherapeutics, Inc.
Anderson KirstinEleven Biotherapeutics, Inc.
BAY CITY CAPITAL FUND I L PEleven Biotherapeutics, Inc.
BAY CITY CAPITAL MANAGEMENT LLCEleven Biotherapeutics, Inc.
BERRY DAVID AEleven Biotherapeutics, Inc.
Bourdow Carrie L.Eleven Biotherapeutics, Inc.
Boxer Asset Management Inc.Eleven Biotherapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Boxer Capital, LLCEleven Biotherapeutics, Inc.

Cannell Thomas REleven Biotherapeutics, Inc.

Celniker AbbieEleven Biotherapeutics, Inc.

CHANEY PAUL GEleven Biotherapeutics, Inc.

Cheng Sohanya RoshanEleven Biotherapeutics, Inc.

Clairmark Investments Ltd.Eleven Biotherapeutics, Inc.

CRAVES FRED BEleven Biotherapeutics, Inc.

DAN LESLIEEleven Biotherapeutics, Inc.

DeCillis ArthurEleven Biotherapeutics, Inc.

DIXON WENDY LEleven Biotherapeutics, Inc.

Drake Patricia M.Eleven Biotherapeutics, Inc.

Duker Jay S.Eleven Biotherapeutics, Inc.

DUNNING RICHARDEleven Biotherapeutics, Inc.

Fitzgerald Richard FEleven Biotherapeutics, Inc.

Flagship Ventures 2007 General Partner LLCEleven Biotherapeutics, Inc.

Flagship Ventures Fund 2007, L.P.Eleven Biotherapeutics, Inc.

Flagship Ventures Fund IV General Partner LLCEleven Biotherapeutics, Inc.

Flagship Ventures Fund IV, L.P.Eleven Biotherapeutics, Inc.

Flagship Ventures Fund IV-Rx, L.P.Eleven Biotherapeutics, Inc.

Forbes MonicaEleven Biotherapeutics, Inc.

Furfine Eric StevenEleven Biotherapeutics, Inc.

GERBER WILLIAM GEleven Biotherapeutics, Inc.

Gertz BarryEleven Biotherapeutics, Inc.

GRACE BROTHERS LTDEleven Biotherapeutics, Inc.

Henderson JaneEleven Biotherapeutics, Inc.

HEYNEKER HERBERT LEleven Biotherapeutics, Inc.

Hodits ReginaEleven Biotherapeutics, Inc.

HOEKSTRA MERL FEleven Biotherapeutics, Inc.

HOGUE BERT WEleven Biotherapeutics, Inc.

Hohneker JohnEleven Biotherapeutics, Inc.

Honig PeterEleven Biotherapeutics, Inc.

HURLY STEPHEN AEleven Biotherapeutics, Inc.

JAFCO Super V3 Investment Limited PartnershipEleven Biotherapeutics, Inc.

Jewett Michael A. S.Eleven Biotherapeutics, Inc.

KANIA EDWIN M JREleven Biotherapeutics, Inc.

Kelly StevenEleven Biotherapeutics, Inc.

Keyes Jason AEleven Biotherapeutics, Inc.

Kim DennisEleven Biotherapeutics, Inc.

Klichinsky MichaelEleven Biotherapeutics, Inc.

LEVIN MARK JEleven Biotherapeutics, Inc.

LEWIS JOSEPHEleven Biotherapeutics, Inc.

LUCERO MICHAEL YBARRAEleven Biotherapeutics, Inc.

LYNCH DANIELEleven Biotherapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Eleven Biotherapeutics, Inc.	Jan 26, 2022	AwardD	623,000	0.00 USD	$0	SEC